窺得兒醫藥 QDEL 深 滬
等待開盤 06-25 09:30:00 美东时间
12.21
+0.275
+2.30%
華盛通- 最 高12.675
- 今 開11.91
- 成交量 152.64万股
- 最 低 11.84
- 昨 收 11.935
- 總市值 8.33亿
- 52周最高 35.575
- 市盈率 靜 --
- 換手率 2.24%
- 52周最低 9.92
- 委 比 -73.97%
- 總股本 6819.10万
- 歷史最高 306.724
- 量 比 1.08
- 振 幅 7.00%
- 歷史最低 9.92
- 每 手 1
- 風險率 6.74%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多QuidelOrtho Appoints Micah Young As CFO, Effective July 6, Succeeding Joseph Busky
Seasoned medical technology finance executive brings more than two decades of leadership at global public companies SAN DIEGO, June 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ:QDEL) ("QuidelOrtho" or the "Company"), a leading global provider of diagnostic solutions, today announced the ...
06-23 19:13
When Blood Compatibility Becomes a Pregnancy Risk
SAN DIEGO, May 21, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 58 of its Science Bytes podcast, focusing on hem...
05-21 21:18
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
Citigroup Maintains Neutral on QuidelOrtho, Lowers Price Target to $13
Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $30 to $13.
05-07 03:26
财报速睇 | 窥得儿医药 2026财年Q1营收6.20亿美元，同比下降10.5%；归母净利润亏损0.92亿美元，同比亏损扩大622.8%
华盛资讯5月6日讯，窥得儿医药公布2026财年Q1业绩，公司Q1营收6.20亿美元，同比下降10.5%，归母净利润亏损0.92亿美元，同比亏损扩大622.8%。
05-06 18:19
财报速睇 | 窥得儿医药 2026财年Q1营收6.20亿美元，同比下降10.5%；归母净利润亏损0.92亿美元，同比亏损扩大622.8%
华盛资讯5月6日讯，窥得儿医药公布2026财年Q1业绩，公司Q1营收6.20亿美元，同比下降10.5%，归母净利润亏损0.92亿美元，同比亏损扩大622.8%。
05-06 08:42
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Understanding and Addressing Syphilis Trends - and What's Being Missed
SAN DIEGO, April 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 57 of its Science Bytes podcast, focusing on e...
04-23 21:32
QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics
– Marks a Milestone in QuidelOrtho's Plans to Accelerate Growth in Point-of-Care Molecular Diagnostics – – Expands Portfolio with Ultra-Fast PCR Platform Designed to Deliver Results in Appro...
04-20 19:12
